Truist Securities Maintains Buy on Merck & Co, Lowers Price Target to $132
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on Merck & Co (NYSE:MRK) but has lowered the price target from $143 to $132.
October 09, 2024 | 4:28 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has maintained a Buy rating on Merck & Co but lowered the price target from $143 to $132, indicating a slightly less optimistic outlook.
The maintenance of a Buy rating suggests continued confidence in Merck's performance, but the lowered price target indicates a tempered outlook. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100